| Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient? D Kegyes, C Constantinescu, L Vrancken, L Rasche, C Gregoire, B Tigu, ... Journal of Hematology & Oncology 15 (1), 78, 2022 | 26 | 2022 |
| Proteasome inhibition in combination with immunotherapies: State-of-the-Art in multiple myeloma D Kegyes, D Gulei, R Drula, D Cenariu, B Tigu, D Dima, A Tanase, ... Blood Reviews, 101100, 2023 | 5 | 2023 |
| COVID-19 impact on chronic myeloid leukemia patients DR Arbore, SM Galdean, D Dima, I Rus, D Kegyes, RG Ababei, ... Journal of Personalized Medicine 12 (11), 1886, 2022 | 4 | 2022 |
| Switching from salvage chemotherapy to immunotherapy in adult B-cell acute lymphoblastic leukemia D Kegyes, C Jitaru, G Ghiaur, S Ciurea, D Hoelzer, C Tomuleasa, ... Blood Reviews 59, 101042, 2023 | 3 | 2023 |
| Design and preclinical testing of an anti‐CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemia AB Tigu, CS Constantinescu, P Teodorescu, D Kegyes, R Munteanu, ... Journal of Cellular and Molecular Medicine 27 (19), 2864-2875, 2023 | 1 | 2023 |
| Immune Therapies of B-cell Acute Lymphoblastic Leukaemia in Children and Adults D Kegyes, G Ghiaur, A Bancos, C Tomuleasa, RP Gale Critical Reviews in Oncology/Hematology, 104317, 2024 | | 2024 |
| Low-Dose Decitabine Plus Venetoclax As Frontline Treatment of Acute Myeloid Leukemia M Peters, C Jitaru, A Bancos, AB Tigu, D Cenariu, C Selicean, V Moisoiu, ... Transplantation and Cellular Therapy 30 (2), S113-S114, 2024 | | 2024 |
| Preclinical Evaluation of an Anti-CD41 CAR T Cell in Acute Megakaryoblastic Leukemia on in Vitro and In Vivo Models AB Tigu, C Constantinescu, P Teodorescu, D Kegyes, R Munteanu, ... Transplantation and Cellular Therapy 30 (2), S99, 2024 | | 2024 |
| A mathematical model of clonal hematopoiesis explaining phase transitions in myeloid leukemia LG Parajdi, X Bai, D Kegyes, C Tomuleasa arXiv preprint arXiv:2401.05316, 2024 | | 2024 |
| Outcomes of CAR-T Cell Therapy Recipients Admitted to the ICU: In Search for a Standard of Care—A Brief Overview and Meta-Analysis of Proportions C Constantinescu, V Moisoiu, B Tigu, D Kegyes, C Tomuleasa Journal of Clinical Medicine 12 (18), 6098, 2023 | | 2023 |
| MDS cells maturation induced by ATRA differentiating agent in myelodysplastic syndromes. D Cenariu, AB Tigu, D Kegyes, M Peters, JT Bergthorsson, V Greiff, ... Studia Universitatis Babes-Bolyai, Historia Artium 68 (2), 2023 | | 2023 |
